All In Biotech

Drug Trial Radar · NCT06361485

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

Last checked: Nov 20, 2026Latest source record: Apr 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Mar 25, 2024

Primary completion

Mar 31, 2027

Study completion Apr 1, 2028

Sponsor

Lead sponsor
R3 Stem CellIndustry
Sponsor type
Industry
Collaborators
R3 Medical Research
First posted
Apr 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Pilot Study that is an open label, prospective, non-controlled study in which the safety and feasibility of Wharton's Jelly (WJ) allograft will be evaluated in 100 participants suffering with low back pain.

Conditions

  • Low Back Pain

Interventions

  • Lumbar Injections with 10cc's of Wharton's Jelly AllograftBiological

    Low Back Injections with Minimal Manipulation Umbilical Cord Tissue

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. C-reactive proteinTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  2. Erythrocyte sedimentation rateTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  3. Alanine transaminase (ALT)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  4. Aspartate transaminase (AST)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  5. Alkaline phosphatase (ALP)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  6. AlbuminTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  7. CreatinineTime frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
  8. Blood Urea Nitrogen (BUN)Time frame: Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • R3 Anti Aging Scottsdale

    Scottsdale, Arizona · Recruiting

  • R3 Anti Aging Beverly Hills

    Beverly Hills, California · Recruiting

  • Scheer Medical Wellness

    New York, New York · Recruiting

  • Dr. Duc (Steve) Le, MD

    Cleveland, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.